Last updated at 19 Oct 2025 01:54 AM
Director
DIN: 09332814
Thomas Immanuveldinakaran is currently associated with 2 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at SARVESWARAS PHARMACEUTICAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09332814.Thomas Immanuveldinakaran is currently involved in 2 different roles. Their most recent position is with NEXAMAG LIFE SCIENCES PRIVATE LIMITED as a Individual Subscriber. The first company Thomas Immanuveldinakaran was appointed to as a director was SARVESWARAS PHARMACEUTICAL PRIVATE LIMITED. Thomas Immanuveldinakaran is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Thomas Immanuveldinakaran is currently associated with 2 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at SARVESWARAS PHARMACEUTICAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09332814.Thomas Immanuveldinakaran is currently involved in 2 different roles. Their most recent position is with NEXAMAG LIFE SCIENCES PRIVATE LIMITED as a Individual Subscriber. The first company Thomas Immanuveldinakaran was appointed to as a director was SARVESWARAS PHARMACEUTICAL PRIVATE LIMITED. Thomas Immanuveldinakaran is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
10 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SARVESWARAS PHARMACEUTICAL PRIVATE LIMITED | Director | 16-Aug-2021 |
| NEXAMAG LIFE SCIENCES PRIVATE LIMITED | Individual Subscriber | 18-Oct-2025 |